Sangamo Therapeutics
SGMO
NASDAQ
IPO2000
about SGMO
Sangamo Therapeutics is a biotechnology company focused on gene therapy and genome editing, developing innovative treatments for genetic disorders and rare diseases such as hemophilia and metabolic conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $0.65 | $0.67 | $0.62 | $191.07M | 4.44M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.08 | n/a | 8.96 | -97.54% | -109.18% | 0% |